Syphilis Screening Tests

Serological diagnostic tests for detection of Treponema pallidum antibodies in patient sera. Available in both screening and confirmatory formats for syphilis diagnosis.

Serological tests for treponema pallidum detection and syphilis diagnosis. Includes both treponemal and non-treponemal assays.

TPHA and RPR tests are serological diagnostic assays for the detection and confirmation of syphilis (Treponema pallidum) infection. These tests are used in blood screening, clinical diagnosis, and infectious disease monitoring across healthcare settings. The tests provide rapid results for patient management and epidemiological surveillance.

High-sensitivity rapid diagnostic tests designed for clinical screening applications. Offer maximum reliability for initial detection of infectious diseases and health conditions.

Serological tests for detection of antibodies and antigens related to infectious diseases. Useful for both acute infection diagnosis and immunity assessment.

High quality, easy-to-use diagnostic tests designed for use in resource poor settings, providing same-day results for timely treatment interventions. Based on agglutination, immuno-dot, immuno-chromatographic and immuno-filtration techniques. Designed for individual or limited sample numbers, making them more economical than ELISA in low throughput laboratories. Tests are quick and easy to perform with results in 3 to 30 minutes, require little or no additional equipment, and can be stored at room temperature for extended periods.

Ready-to-use rapid tests for the quick detection of various infectious disease markers. These tests enable rapid screening and identification of bacterial, viral, parasitic, and fungal pathogens.

Serum-based rapid tests for detection of antigens and antibodies in clinical specimens. These IVD reagents enable quick diagnostic assessment for infectious disease screening and immunological testing. Manufactured under ISO certification with formulations designed for point-of-care and laboratory use.

Rapid Tests are in vitro diagnostic reagents designed for rapid detection and identification across multiple clinical applications including infectious diseases, cancer markers, and fertility screening. These point-of-care tests deliver accurate results in seconds, suitable for use in clinical laboratories, blood banks, and healthcare facilities.

Rapid diagnostic tests for infectious disease and clinical marker detection with quick turnaround times. These tests are designed for clinical departments requiring expedited results.

Quick and easy-to-use rapid tests designed for home monitoring and health screening. The tests are developed with a focus on accessibility and ease of use for patient self-testing applications.

Rapid diagnostic tests for clinical microbiology applications, providing quick pathogen detection and identification.